Table 2.
Spearman correlations between ALOX15 mRNA level and laboratory and clinical characteristics
| Correlation | r value | P value | |
|---|---|---|---|
| ALOX15 mRNA level (− ΔCt value) | Age | − 0.116 | 0.433 |
| Tissue eosinophils (%) | 0.565 | < 0.001 | |
| Tissue neutrophils (%) | − 0.167 | 0.256 | |
| Nasal obstruction score | 0.149 | 0.312 | |
| Rhinorrhea score | 0.225 | 0.124 | |
| Olfaction score | 0.400 | 0.005 | |
| Facial pain or headache score | 0.056 | 0.706 | |
| Total VAS score | 0.383 | 0.007 | |
| CT score | 0.150 | 0.309 | |
| E/M ratio | 0.463 | 0.001 | |
| Endoscopy score | 0.409 | 0.004 | |
| Blood eosinophils (%) | 0.395 | 0.006 | |
| Blood neutrophils (%) | − 0.159 | 0.280 |
ALOX15 arachidonate 15-lipoxygenase, VAS visual analogue scale, CT computed tomography, E/M ethmoid/maxillary sinus. Italic values are significant at P < 0.05